Gui‐Qiang Wang
- Infectious Diseases top 5%
- Neurology top 5%
- Epidemiology
- Hepatology top 5%
- Molecular Biology
- Co-authors
- Yan WangHao ChengJiandan QianTiantian YaoJian‐Wu YuShuchen LiZhao WuHong Zhao
- Topics
- Hepatitis C virus research (6 papers)Liver Disease Diagnosis and Treatment (5 papers)Hepatitis B Virus Studies (5 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Gui‐Qiang Wang
11 papers receiving 939 citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Infectious Diseases 539
- Neurology 229
- Epidemiology 224
- Hepatology 197
- Molecular Biology 92
Countries citing papers authored by Gui‐Qiang Wang
This map shows the geographic impact of Gui‐Qiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gui‐Qiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gui‐Qiang Wang more than expected).
Fields of papers citing papers by Gui‐Qiang Wang
This network shows the impact of papers produced by Gui‐Qiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gui‐Qiang Wang. The network helps show where Gui‐Qiang Wang may publish in the future.
Co-authorship network of co-authors of Gui‐Qiang Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Gui‐Qiang Wang. A scholar is included among the top collaborators of Gui‐Qiang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gui‐Qiang Wang. Gui‐Qiang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 1 | |
| 4 | Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19breakdown → | 360 |
| 5 | 345 | |
| 6 | 70 | |
| 7 | 2 | |
| 8 | 31 | |
| 9 | 17 | |
| 10 | 104 | |
| 11 | 42 |
About Gui‐Qiang Wang
Gui‐Qiang Wang is a scholar working on Hepatology, Applied Microbiology and Biotechnology and Epidemiology, having authored 11 papers that have together received 979 indexed citations. Recurring topics across this work include Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (5 papers). The work is most often cited by research in Infectious Diseases (539 citations), Hepatology (197 citations) and Neurology (229 citations). Gui‐Qiang Wang has collaborated with scholars based in China and United States. Frequent co-authors include Yan Wang, Hao Cheng, Jiandan Qian, Tiantian Yao, Jian‐Wu Yu, Shuchen Li, Zhao Wu, Hong Zhao, Lijie Sun and Xiaoguang Li. Their work appears in journals such as Hepatology, Journal of Medical Virology and Journal of Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.